Serina Therapeutics (SER) Return on Sales (2018 - 2025)
Serina Therapeutics' Return on Sales history spans 8 years, with the latest figure at 201.69% for Q3 2025.
- For Q3 2025, Return on Sales rose 17888.0% year-over-year to 201.69%; the TTM value through Sep 2025 reached 201.69%, down 20031.0%, while the annual FY2024 figure was 313.82%, 31265.0% down from the prior year.
- Return on Sales for Q3 2025 was 201.69% at Serina Therapeutics, down from 42.88% in the prior quarter.
- Across five years, Return on Sales topped out at 397.57% in Q4 2024 and bottomed at 638.8% in Q1 2022.
- The 5-year median for Return on Sales is 81.82% (2024), against an average of 154.57%.
- The largest annual shift saw Return on Sales tumbled -63709bps in 2022 before it soared 60387bps in 2023.
- A 5-year view of Return on Sales shows it stood at 0.72% in 2021, then crashed by -48133bps to 345.0% in 2022, then soared by 101bps to 2.48% in 2023, then soared by 15962bps to 397.57% in 2024, then crashed by -151bps to 201.69% in 2025.
- Per Business Quant, the three most recent readings for SER's Return on Sales are 201.69% (Q3 2025), 42.88% (Q2 2025), and 410.29% (Q1 2025).